You are an elite MBBS pharmacology professor, clinical pharmacologist, medical educator, pathophysiologist, and examination coach. Create a COMPLETE LEARNING NOTE for the topic(s) provided. The goal is NOT merely to summarize information. The goal is to teach the topic from absolute beginner level to MBBS examination mastery level. Assume the student has never seen the topic before. Write in extremely clear, plain English. Use language simple enough for a 9-year-old child to understand initially, then gradually build to MBBS level understanding. Never sacrifice understanding for brevity. Do not use unexplained jargon. Whenever a technical term is introduced: 1. Define it. 2. Explain why it matters. 3. Explain it using a simple analogy. 4. Explain it again in proper medical language. For every topic, use the following structure. --- SECTION 1: BIG PICTURE OVERVIEW Start with: "What problem does this drug class solve?" Explain: Why the disease occurs Why the microorganism survives What the drug is trying to achieve Where the drug acts Create a mental picture before discussing drugs. --- SECTION 2: BUILD THE FOUNDATION Before discussing drugs: Explain all background physiology. Explain all background microbiology. Explain all relevant pathology. Answer: What is normally happening? What goes wrong? Why does it go wrong? Where can drugs intervene? Use diagrams in text format where appropriate. Example: Bacterium ↓ Needs cell wall ↓ Cell wall keeps bacterium alive ↓ Drug blocks wall formation ↓ Wall becomes weak ↓ Bacterium dies --- SECTION 3: DRUG CLASS FRAMEWORK For each drug class explain: Definition Mechanism of action Why the mechanism works Spectrum of activity Important examples Clinical uses Adverse effects Contraindications Drug interactions Resistance mechanisms High-yield examination facts Common MCQs Most frequently tested concepts --- SECTION 4: TEACH USING ANALOGIES Create memorable analogies. Examples: Penicillin: "The bacterial cell wall is like a brick wall protecting a house. Penicillin prevents the workers from laying the bricks." Aminoglycosides: "The bacterial ribosome is like a factory producing products. Aminoglycosides force the factory to produce defective products." Sulfonamides: "Like cutting off a city's food supply." Always use vivid memorable analogies. --- SECTION 5: STEP-BY-STEP CLINICAL REASONING Teach how a doctor thinks. Example: Patient has pneumonia. Question 1: What organisms commonly cause it? Question 2: Which drugs cover those organisms? Question 3: Which drug reaches the lungs well? Question 4: What patient factors influence choice? Question 5: What adverse effects must be considered? Walk through reasoning systematically. --- SECTION 6: MEMORY TOOLS Create: Mnemonics Memory stories Visual memory tricks Drug comparison tables Rapid review boxes Focus only on useful mnemonics. --- SECTION 7: EXAMINER'S CORNER For each topic include: Most tested facts Most likely essay questions Most likely short notes Most likely viva questions Most likely MCQs Common traps students fall into How examiners phrase questions - SECTION 9: HIGH-YIELD REVISION SHEET End with: One-page revision summary Most important facts Must-know drugs Must-know toxicities Must-know mechanisms Must-know clinical uses Exam emergency facts --- SECTION 10: SELF-ASSESSMENT Create: 10 short-answer questions Provide answers with explanations. --- SPECIAL INSTRUCTIONS Do not assume prior knowledge. Teach before summarizing. Explain every mechanism step-by-step. Explain every adverse effect by linking it to physiology and pathophysiology. When discussing drugs, always answer: "What exactly is the drug doing?" "Why does that action help the patient?" "Why does that action produce the side effects?" "Why might resistance develop?" Use tables wherever helpful. Use comparison tables extensively. Make the note so comprehensive that an MBBS student can use it as their primary learning resource without needing another source for conceptual understanding. TOPICS TO COVER: NSAIDs

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Loading Image

I now have rich, authoritative data from multiple textbooks. Let me compose the complete, comprehensive learning note.

COMPLETE LEARNING NOTE: NSAIDs (Non-Steroidal Anti-Inflammatory Drugs)

From Absolute Beginner to MBBS Examination Mastery

SECTION 1: BIG PICTURE OVERVIEW

"What Problem Does This Drug Class Solve?"

Imagine you accidentally hit your thumb with a hammer. Within minutes, your thumb turns red, swells up, feels hot, and hurts. You cannot use it comfortably. This is inflammation - your body's emergency repair system switching on.

Inflammation is not always your enemy. In fact, it is often your friend. It brings immune cells to fight infection and starts the healing process. BUT - sometimes inflammation becomes excessive, prolonged, and damaging. In diseases like arthritis, it keeps going for years, destroying the very joints it is supposed to protect. In fever, it makes the brain overheat. In period pain, it causes the uterus to cramp. In headaches and post-surgical pain, it creates unbearable suffering.

The central problem: Inflammation produces chemicals called prostaglandins (think of them as little chemical alarm signals). These prostaglandins cause:

Pain - by sensitizing nerve endings so that even light touch hurts
Fever - by resetting the brain's thermostat to a higher temperature
Swelling - by making blood vessels leaky so fluid pours into tissue
Redness and heat - by increasing blood flow to the area

What NSAIDs do: They block the production of prostaglandins at their source, like shutting off the alarm system factory. Less prostaglandin = less pain, less fever, less swelling.

The target of NSAIDs: An enzyme called cyclooxygenase (COX) - the key enzyme that makes prostaglandins. No COX activity = no prostaglandins = relief.

In one sentence: NSAIDs are drugs that relieve pain, reduce fever, and decrease inflammation by blocking the enzyme (COX) that produces the chemical alarms (prostaglandins) of the body.

SECTION 2: BUILD THE FOUNDATION

2A. Normal Physiology - The Arachidonic Acid Pathway

Before understanding NSAIDs, you need to understand what happens normally inside your cells when injury or inflammation occurs.

Step 1: Membrane Phospholipids

Every cell in your body is surrounded by a membrane (like the skin of a soap bubble). This membrane contains fat-like molecules called phospholipids. Tucked inside these phospholipids is a fatty acid called arachidonic acid (AA).

Think of arachidonic acid as a sleeping soldier inside the membrane, waiting for an emergency signal.

Step 2: The Emergency Signal - Phospholipase A2

When a cell is damaged, or when cytokines (immune signaling molecules) arrive, an enzyme called phospholipase A2 wakes up. It cuts arachidonic acid free from the membrane.

Think of phospholipase A2 as the officer who shouts "Wake up soldiers! We have an emergency!"

Step 3: The Fork in the Road - Two Paths for Arachidonic Acid

Once free, arachidonic acid can take one of two roads:

ARACHIDONIC ACID (freed from membrane)
         |
    _____|_____
    |         |
  COX        5-Lipoxygenase
  PATH         PATH
    |              |
Prostaglandins  Leukotrienes
Thromboxane A2  (cause bronchoconstriction
Prostacyclin     and allergic reactions)
    |
These cause:
PAIN, FEVER, INFLAMMATION,
platelet aggregation, gastric protection

NSAIDs block the COX path. They do NOT block the lipoxygenase path. This is why NSAIDs reduce pain and fever but do NOT treat asthma (which requires leukotriene blockers like montelukast).

Step 4: The COX Enzyme - Two Forms

This is where it gets really important. There are two main forms of the COX enzyme:

Feature	COX-1	COX-2
Expression	Present all the time ("constitutive") in most cells	Switched on ("induced") by inflammation, injury, cytokines
Location	Stomach lining, platelets, kidneys, blood vessels	Inflammatory cells, kidney, brain, endothelium
Main products	Gastric protective prostaglandins (PGE2, PGI2), thromboxane A2 in platelets	PGE2 and PGI2 at sites of inflammation
Main function	Housekeeper - protects stomach, helps platelets clump, maintains kidney blood flow	Emergency worker - drives inflammation, pain, fever
Analogy	The maintenance crew keeping the building running	The fire brigade called in when there is a fire

This distinction is the most important thing to understand about NSAIDs. When you give a drug that blocks BOTH COX-1 and COX-2 (a traditional/non-selective NSAID like ibuprofen), you get:

Desired: Less inflammation, less pain, less fever (COX-2 block)
Unwanted: Stomach ulcers (COX-1 block in stomach), bleeding tendency (COX-1 block in platelets), kidney problems (COX-1+2 block in kidney)

2B. Prostaglandins and Their Actions - What They Do

Prostaglandins (PGs) are local signaling molecules - they act close to where they are made, not at distant sites like hormones. The major ones:

Prostaglandin	Made Where	Key Effects
PGE2	Widely (inflammatory cells, stomach, kidney, brain)	Pain sensitization, fever, gastric protection, vasodilation, uterine contraction
PGI2 (Prostacyclin)	Vascular endothelium	Vasodilation, prevents platelet clumping, protects kidneys
TxA2 (Thromboxane A2)	Platelets	Powerful platelet aggregation, vasoconstriction
PGD2	Mast cells	Allergic inflammation, bronchoconstriction
PGF2α	Uterus, lungs	Uterine contraction, bronchoconstriction

Key insight for NSAID pharmacology:

COX-1 in platelets → TxA2 → platelet aggregation. Aspirin IRREVERSIBLY blocks this → anti-platelet effect lasts 7-10 days (platelet lifetime)
COX-2 in endothelium → PGI2 → prevents platelet clumping and dilates vessels. Selective COX-2 inhibitors block this without blocking TxA2 → NET EFFECT: THROMBOSIS RISK

2C. How Prostaglandins Cause Pain

Pain nerve endings (nociceptors) normally need a fairly strong stimulus to fire. PGE2 and PGI2 lower the threshold of these nociceptors - they become hypersensitive. Even light touch, normal pressure, or mild temperature changes now cause pain. This is called peripheral sensitization.

Think of it this way: normally, a door needs a hard push to open. PGE2 oils the hinges so the door swings open with the lightest touch.

Centrally, PGE2 in the spinal cord causes central sensitization - the spinal cord neurons become hyperexcitable, amplifying pain signals from the periphery. NSAIDs reduce both peripheral and central sensitization.

2D. How Prostaglandins Cause Fever

The brain has a temperature control center in the hypothalamus (think of it as a thermostat). Normally it is set at 37°C. When infection or inflammation occurs:

Immune cells release cytokines - IL-1β, IL-6, TNF-α (messengers that say "emergency!")
Cytokines act on the hypothalamus, inducing COX-2
COX-2 makes PGE2 in the hypothalamus
PGE2 resets the thermostat to 39°C or higher
Body generates more heat and reduces heat loss
Result: Fever

NSAIDs block COX-2 in the hypothalamus → block PGE2 production → thermostat resets to normal → fever breaks.

Note: Paracetamol (acetaminophen) also works centrally but has no peripheral anti-inflammatory effect.

2E. How Prostaglandins Protect the Stomach

This is critical for understanding NSAID side effects.

The stomach normally digests your food with strong acid. It needs to protect itself from being digested too. It does this by:

Making a thick layer of mucus (physical barrier)
Secreting bicarbonate (chemical buffer against acid)
Maintaining good blood flow to keep cells healthy
Limiting acid secretion

COX-1 in the stomach lining makes PGE2 and PGI2, which stimulate all of the above protective mechanisms.

Block COX-1 (with non-selective NSAIDs) → Less gastric prostaglandins → Thin mucus, less bicarbonate, poor blood flow, more acid → ULCERS

This is why gastric ulceration is the #1 side effect of non-selective NSAIDs.

SECTION 3: DRUG CLASS FRAMEWORK

3A. Definition of NSAIDs

NSAIDs = Non-Steroidal Anti-Inflammatory Drugs

"Non-steroidal" = they reduce inflammation WITHOUT using steroids (like cortisone)
"Anti-inflammatory" = they reduce the inflammatory process
The term distinguishes them from steroids (like prednisolone), which also reduce inflammation but work differently and have different side effects

They also have:

Analgesic (pain-relieving) effect
Antipyretic (fever-reducing) effect

Some, like aspirin, additionally have antiplatelet effect at low doses.

3B. Classification of NSAIDs

By COX Selectivity:

Class	Examples	COX-1:COX-2 Inhibition
Non-selective (traditional) NSAIDs (tNSAIDs)	Aspirin, ibuprofen, naproxen, indomethacin, diclofenac, ketorolac	Inhibit both COX-1 and COX-2
Preferential COX-2 inhibitors	Meloxicam, nimesulide, diclofenac (higher doses), nabumetone	Slightly prefer COX-2 but still inhibit COX-1 at higher doses
Selective COX-2 inhibitors (Coxibs)	Celecoxib, etoricoxib, rofecoxib (withdrawn), valdecoxib (withdrawn)	Selectively inhibit COX-2, spare COX-1

By Chemical Structure (important for exams):

Chemical Group	Examples
Salicylic acids	Aspirin, diflunisal
Acetic acids	Indomethacin, ketorolac, diclofenac, etodolac, sulindac, tolmetin, nabumetone
Propionic acids	Ibuprofen, naproxen, ketoprofen, flurbiprofen, fenoprofen
Fenamic acids (Anthranilic acids)	Mefenamic acid, meclofenamate
Enolic acids (Oxicams)	Piroxicam, meloxicam, tenoxicam
Diarylheterocyclics	Celecoxib, rofecoxib, valdecoxib, etoricoxib
Others	Acetaminophen/Paracetamol (special category)

(Refer to figure below showing chemical similarity, COX selectivity, and plasma half-life)

Classification of NSAIDs by chemical similarity, COX selectivity, and plasma half-life

Classification of NSAIDs by chemical similarity (A), COX isoform selectivity (B), and plasma t½ (C). - Goodman & Gilman's

3C. Mechanism of Action of NSAIDs

The Core Mechanism (applicable to all NSAIDs):

NSAIDs inhibit the enzyme cyclooxygenase (COX), also called prostaglandin G/H synthase (PGG/H synthase). This enzyme converts arachidonic acid into PGG2 and then PGH2, the unstable intermediates from which all prostaglandins, thromboxane A2, and prostacyclin are eventually made.

No COX → No PGH2 → No downstream prostaglandins, thromboxanes, or prostacyclin

The molecular detail:

COX enzymes have a hydrophobic channel through which arachidonic acid slides to reach the catalytic site deep inside the enzyme
Most NSAIDs physically block this channel (reversibly)
Aspirin is unique - it covalently acetylates a serine residue (Ser-530 in COX-1, Ser-516 in COX-2) inside the channel, permanently destroying enzyme activity

Why COX-2-selective drugs work structurally: COX-2 has a larger, wider binding channel with an extra side pocket, compared to COX-1. COX-2-selective inhibitors (coxibs) have bulky side groups that fit into this extra pocket in COX-2 but are physically blocked from entering the smaller COX-1 channel. It is like having a key with an extra bump - it only fits the larger lock.

3D. Aspirin - A Drug Worthy of Special Study

Aspirin (acetylsalicylic acid) is the oldest and most unique NSAID. It deserves special attention because it behaves differently from all other NSAIDs.

What makes aspirin unique:

Irreversible inhibition - Aspirin acetylates COX enzymes covalently. Once acetylated, the enzyme is permanently destroyed. The cell has to make new enzyme protein (which takes hours to days). Other NSAIDs only reversibly block COX.
Dose-dependent effects:

Dose	Effect	Mechanism
Low (75-325 mg/day)	Antiplatelet (anti-thrombotic)	Irreversibly inhibits COX-1 in platelets → no TxA2 → no platelet aggregation
Moderate (325-650 mg every 4-6 hrs)	Analgesic and antipyretic	COX inhibition in peripheral tissues and hypothalamus
High (>3-4 g/day)	Anti-inflammatory	Sustained high COX inhibition
Very high (toxic)	Salicylism/salicylate toxicity	See adverse effects

Platelet effect is permanent for platelet lifetime: Platelets have no nucleus (they cannot make new protein). When aspirin kills their COX-1, it stays dead for the entire 7-10 day platelet lifespan. This is why aspirin's antiplatelet effect requires only once-daily dosing, and why you must stop aspirin 7-10 days before surgery.

Other NSAIDs (like ibuprofen) also inhibit platelet COX-1, BUT reversibly - so the effect wears off when the drug leaves the system.

Clinical impact: Ibuprofen can compete with aspirin for binding to COX-1. If a patient on low-dose aspirin (for heart protection) takes ibuprofen first, the ibuprofen binds reversibly to COX-1 and physically blocks aspirin from getting in to acetylate it. When ibuprofen leaves, COX-1 is intact again - aspirin's protective effect is undermined. This is a major drug interaction.

3E. Individual NSAIDs - Key Properties

IBUPROFEN

Propionic acid group
Short half-life (~2 hours) - needs dosing 3-4 times daily
One of the safest NSAIDs for GI tract (still causes GI problems but less than indomethacin)
OTC availability in most countries
Used for: mild to moderate pain, dysmenorrhea, fever, arthritis
Can close patent ductus arteriosus (PDA) in premature neonates (COX inhibition reduces PGE2 that keeps ductus open)
Special: Ibuprofen may cause hypogonadism with prolonged use

NAPROXEN

Propionic acid group
Long half-life (~14 hours) - twice daily dosing
Among the non-selective NSAIDs, naproxen has relatively lower cardiovascular risk compared to ibuprofen or diclofenac
Used for: musculoskeletal pain, dysmenorrhea, gout, arthritis

INDOMETHACIN

Acetic acid group
Very potent COX inhibitor
Most GI-toxic of common NSAIDs
High CNS penetration - causes headache, dizziness, confusion (especially in elderly)
Special uses: acute gout (drug of choice in some guidelines), patent ductus arteriosus closure in neonates (more commonly used than ibuprofen in some centers), ankylosing spondylitis, pericarditis
High anti-inflammatory potency makes it preferred for acute crystal arthropathies

KETOROLAC

Acetic acid group
One of the most potent analgesic NSAIDs
Available IV/IM - the only parenteral NSAID widely used for short-term pain management
Maximum 5 days use (high GI/renal toxicity risk with longer use)
Used for: post-operative pain, renal colic (given IV)
NOT for chronic use

DICLOFENAC

Phenylacetic acid group
Moderate COX-2 preference among traditional NSAIDs (though not truly selective)
Available oral, topical (gel), IV
Used for: musculoskeletal pain, arthritis, dysmenorrhea
Topical diclofenac = effective for local pain with minimal systemic absorption

PIROXICAM

Enolic acid (Oxicam) group
Extremely long half-life (45-50 hours) - once daily dosing
High GI toxicity (long half-life means sustained COX-1 inhibition in stomach)
Risk of gastric bleeding is higher than shorter-acting NSAIDs
Used for: arthritis (convenient once-daily)

MELOXICAM

Enolic acid (Oxicam) group
Preferential COX-2 inhibitor (not fully selective, but preference for COX-2)
Better GI tolerability than non-selective NSAIDs
Once-daily dosing
Used for: osteoarthritis, rheumatoid arthritis

MEFENAMIC ACID

Fenamic acid group
Commonly used for dysmenorrhea (period pain) - dual action: COX inhibition + blocks prostaglandin receptor
Short-term use only (not beyond 7 days)
Can cause hemolytic anemia with prolonged use

CELECOXIB

Diarylheterocyclic (sulfonamide) - COX-2 selective inhibitor (Coxib)
Spares COX-1 → much lower gastric ulcer risk than non-selective NSAIDs
Does NOT inhibit platelet aggregation (platelets use COX-1, not COX-2)
Cardiovascular risk: Inhibits PGI2 (from endothelial COX-2) without inhibiting TxA2 → prothrombotic imbalance → increased risk of MI and stroke
Contraindicated in sulfonamide allergy (celecoxib has a sulfonamide side chain)
Used for: osteoarthritis, rheumatoid arthritis, familial adenomatous polyposis (reduces colonic polyps)
Currently the only commercially available coxib after rofecoxib/valdecoxib withdrawals

ROFECOXIB (withdrawn) and VALDECOXIB (withdrawn)

Highly selective COX-2 inhibitors
Withdrawn from market due to significantly increased cardiovascular events (VIGOR trial showed rofecoxib doubled MI risk vs. naproxen)
Landmark lesson in pharmacovigilance

PARACETAMOL/ACETAMINOPHEN

Technically not a classic NSAID (no peripheral anti-inflammatory effect at usual doses)
Acts centrally: inhibits a COX variant in the CNS (possibly COX-3 or the peroxide site of COX enzymes)
Antipyretic + analgesic - but NO significant anti-inflammatory effect
No gastric side effects (does not inhibit gastric COX-1)
No platelet effect
Key danger: Hepatotoxicity in overdose
Mechanism of hepatotoxicity: Normal doses are conjugated safely. Overdose overwhelms conjugation, metabolized by CYP2E1 to toxic metabolite NAPQI (N-acetyl-p-benzoquinoneimine). NAPQI depletes glutathione and binds liver proteins → centrilobular necrosis
Antidote: N-Acetylcysteine (NAC) - replenishes glutathione

3F. Adverse Effects of NSAIDs - Explained Mechanistically

1. GASTROINTESTINAL EFFECTS (Most Common)

Mechanism: NSAIDs reduce gastric mucosal prostaglandins (COX-1 inhibition) + direct mucosal irritation (acidic drug damages mucosa directly).

Less PGE2 and PGI2 in stomach → thinner mucus layer → less bicarbonate → reduced mucosal blood flow → reduced ability to resist acid → erosions, ulcers, bleeding, perforation

Spectrum: Dyspepsia (most common, 10-30%), gastric erosions, peptic ulcer disease, GI bleeding (most dangerous), perforation.

Risk factors for GI toxicity:

Age >60
History of peptic ulcer
H. pylori infection
Concomitant corticosteroids or anticoagulants
High dose or long duration NSAID use
Non-selective NSAIDs (not coxibs)
Piroxicam has higher GI risk than ibuprofen

Prevention:

Use COX-2 selective inhibitors (celecoxib)
Add a proton pump inhibitor (PPI) like omeprazole
Use the lowest effective dose
If both GI and CV protection needed: celecoxib + PPI is common strategy

2. CARDIOVASCULAR EFFECTS

Mechanism:

COX-2 in vascular endothelium makes PGI2 (prostacyclin) → vasodilates and prevents platelet aggregation
COX-1 in platelets makes TxA2 → promotes platelet aggregation and vasoconstriction
Normal balance: PGI2 vs TxA2 = pro-thrombotic vs anti-thrombotic balance

Selective COX-2 inhibitors (Coxibs): Block endothelial PGI2 WITHOUT blocking platelet TxA2 → TxA2 wins → pro-thrombotic state → increased MI and stroke risk.

Non-selective NSAIDs: Block both, but in high-risk patients (existing CV disease), the loss of PGI2 still tips the balance.

Naproxen exception: Among non-selective NSAIDs, naproxen appears to have the lowest cardiovascular risk, possibly because its long half-life provides more sustained TxA2 inhibition relative to PGI2.

Current guidelines: NSAIDs and coxibs should be avoided wherever possible in patients with ischemic heart disease, previous thrombosis, or poorly controlled hypertension. When needed, use the lowest dose for the shortest duration.

3. RENAL EFFECTS

Background physiology: Prostaglandins (PGE2 and PGI2) produced in the kidney dilate the afferent arteriole and help maintain glomerular filtration rate (GFR) and renal blood flow. This is especially important when the circulation is stressed (heart failure, dehydration, liver cirrhosis, use of ACE inhibitors or diuretics).

Mechanism of NSAID renal toxicity: In normal people with healthy circulation and good hydration, prostaglandins are not critical for kidney function. But in a person with poor blood flow to the kidney (heart failure, dehydration), prostaglandins are working hard to dilate the kidney's arteries and maintain filtration.

Block COX → Block prostaglandins → Kidney arteries constrict → GFR falls → Acute Kidney Injury (AKI)

Other renal effects:

Salt and water retention → edema, worsening hypertension, worsening heart failure
Hyponatremia (rare)
Hyperkalemia (reduced aldosterone effect due to reduced renin from prostaglandin inhibition)
Interstitial nephritis (rare, idiosyncratic) - seen especially with fenoprofen, ibuprofen - can be associated with nephrotic syndrome (minimal change disease pattern)

Note: Both COX-1 and COX-2 are expressed in the kidney. Even COX-2-selective inhibitors cause renal adverse effects.

4. PLATELET AND BLEEDING EFFECTS

Mechanism: COX-1 in platelets makes TxA2 → promotes platelet aggregation. NSAIDs block this → impaired platelet aggregation → prolonged bleeding time.

Non-selective NSAIDs: Reversible inhibition - effect lasts as long as drug is in system (usually 4-12 hours depending on drug) Aspirin: Irreversible - lasts 7-10 days (platelet lifetime) Coxibs (celecoxib): Do NOT significantly inhibit platelet aggregation (platelets use COX-1, which coxibs spare)

Clinical implications:

Stop NSAIDs before elective surgery (aspirin: 7-10 days; others: 1-3 half-lives before)
Avoid NSAIDs in patients on anticoagulants (dual risk: impaired platelet function + GI ulcer that bleeds)

5. RESPIRATORY EFFECTS - ASPIRIN-EXACERBATED RESPIRATORY DISEASE (AERD)

Previously called: Aspirin-Sensitive Asthma or Samter's Triad (Asthma + Nasal polyps + Aspirin sensitivity)

Mechanism (important for exams):

When COX is blocked, arachidonic acid cannot go down the prostaglandin pathway. It is then shunted down the lipoxygenase pathway → more leukotrienes (LTC4, LTD4, LTE4) → bronchoconstriction, bronchospasm

This is why asthmatics can get severe bronchospasm with aspirin or any non-selective NSAID. Patients with nasal polyps are at highest risk.

All NSAIDs (including coxibs) can potentially trigger this - avoid in AERD

6. REYE'S SYNDROME (Aspirin-specific)

Aspirin in children under 12 years with viral infections (especially influenza or chickenpox) → can cause Reye's syndrome = acute non-inflammatory encephalopathy + fatty liver degeneration

Mechanism: Aspirin appears to interfere with mitochondrial function, especially when viral infection has already stressed hepatic mitochondria.

Aspirin is therefore CONTRAINDICATED in children and adolescents with febrile viral illness. Use paracetamol or ibuprofen instead.

7. SALICYLATE TOXICITY (Aspirin overdose)

Stages:

Early: Nausea, vomiting, tinnitus (ringing in ears), dizziness
Intermediate: Respiratory alkalosis (aspirin directly stimulates respiratory center → hyperventilation → CO2 blown off)
Late (severe overdose): Metabolic acidosis (accumulation of organic acids, uncoupling of oxidative phosphorylation) PLUS respiratory alkalosis = mixed acid-base disorder (classic exam finding)
Terminal: Hyperthermia, convulsions, coma, pulmonary edema

Treatment: Urine alkalinization with sodium bicarbonate (ion trapping - ionized salicylate cannot cross tubular cells back into blood, so gets excreted in urine), dialysis in severe cases.

8. DRUG INTERACTIONS (Key ones)

NSAID	Drug	Interaction	Mechanism
All NSAIDs	Warfarin	Increased bleeding risk	Displace warfarin from protein binding + GI ulceration
All NSAIDs	ACE inhibitors / ARBs	Worsened renal function	Both reduce renal prostaglandins; combined = AKI risk
All NSAIDs	Diuretics	Reduced diuretic effect + AKI	NSAIDs retain Na+; reduce renal prostaglandins
All NSAIDs	Lithium	Increased lithium toxicity	NSAIDs reduce lithium excretion by kidneys
All NSAIDs	Methotrexate	Methotrexate toxicity	NSAIDs reduce renal tubular secretion of methotrexate
Ibuprofen	Aspirin (low dose)	Reduced aspirin antiplatelet effect	Ibuprofen blocks aspirin's access to COX-1
Aspirin	NSAIDs	Same as above

3G. Contraindications

Absolute:

Active peptic ulcer disease (non-selective NSAIDs, relative for coxibs with PPI)
Severe renal failure
Severe hepatic failure
Aspirin in children/adolescents with viral illness (Reye's syndrome risk)
Celecoxib in sulfonamide allergy
Third trimester of pregnancy (risk of premature closure of ductus arteriosus, delayed labor, oligohydramnios, pulmonary hypertension)

Relative/Use with caution:

Asthma (risk of AERD) - use with extreme caution
Heart failure
Hypertension
History of GI bleeding or ulcer
Elderly patients
Pregnancy (first trimester: limited; second trimester: caution; third trimester: contraindicated)
Concomitant anticoagulant use
Renal impairment (even mild)
Hepatic impairment

3H. Specific Clinical Uses

Condition	Drug(s) of Choice	Why
Mild-moderate pain	Ibuprofen, naproxen	Effective, relatively safe
Dysmenorrhea (period pain)	Mefenamic acid, ibuprofen, naproxen	Prostaglandin drives uterine cramps; COX inhibition relieves
Acute gout	Indomethacin, ibuprofen, naproxen	Potent anti-inflammatory; indomethacin fastest onset
Osteoarthritis	Ibuprofen, diclofenac, celecoxib (if GI risk)	Reduce inflammation and pain
Rheumatoid arthritis (symptomatic)	NSAIDs as adjuncts to DMARDs	Symptom relief; do not modify disease
Ankylosing spondylitis	Indomethacin, diclofenac, naproxen	High anti-inflammatory potency needed
Patent ductus arteriosus (premature neonates)	Indomethacin, ibuprofen IV	Block PGE2 that keeps ductus open
Fever	Ibuprofen, paracetamol	Antipyretic via COX-2 inhibition in hypothalamus
Post-operative pain	Ketorolac IV/IM	Parenteral NSAID; opioid-sparing
Pericarditis	Ibuprofen, aspirin	Anti-inflammatory
Familial adenomatous polyposis (FAP)	Celecoxib	COX-2 overexpressed in colonic polyps; COX-2 inhibition reduces polyp formation
Antiplatelet (coronary artery disease, stroke prevention)	Aspirin (low dose: 75-150 mg)	Irreversible COX-1 block → permanent antiplatelet effect
Preeclampsia prevention	Aspirin (low dose)	Anti-thrombotic; reduces thromboxane-mediated placental vasoconstriction
Migraine (acute)	Ibuprofen, naproxen, aspirin	Prostaglandin-mediated vasodilation and sensitization
Renal colic	Ketorolac IV, diclofenac	Reduce ureteral prostaglandin-driven spasm + analgesic

SECTION 4: TEACH USING ANALOGIES

Analogy 1: The Alarm Factory (Core Mechanism)

Imagine your body has a factory that produces "Pain Alarm" chemicals (prostaglandins). When you are injured, the factory goes into overdrive - churning out alarm after alarm. You feel pain, you burn with fever, you swell up.

NSAIDs are workers who sneak into the factory and break the main machine (COX enzyme). No machine = no alarm chemicals = no pain signals sent.

Non-selective NSAIDs break ALL the machines everywhere - including the machines in the stomach that produce "protective alarm" chemicals (which actually protect the stomach lining). Break those too → stomach unprotected → ulcer.

COX-2 selective NSAIDs are like saboteurs who only break the emergency alarm machines (COX-2, in inflammatory cells) but leave the maintenance machines (COX-1, in stomach/platelets) alone.

Analogy 2: Aspirin and the Suicide Mission

Most NSAIDs are like someone sitting on the factory machine to stop it. They get up, the machine starts again. Reversible.

Aspirin is like a saboteur who pours superglue into the machine and then leaves. The machine is destroyed forever. Irreversible. A new machine has to be built (takes time).

For platelets (which cannot build new machines because they have no factory - no nucleus), aspirin's damage is permanent for the platelet's entire lifetime (7-10 days).

Analogy 3: COX-1 vs COX-2 - The Two Fire Stations

COX-1 = The old, permanent fire station that runs all the time. It handles routine calls: protecting the stomach, helping platelets form blood clots, maintaining kidney blood flow. Essential everyday.

COX-2 = A temporary emergency fire station opened only during a crisis (inflammation, injury). It handles the inflammation response.

Non-selective NSAIDs = Shut down BOTH fire stations. Inflammation is controlled, but now the stomach has no protection and platelets cannot clump.

Coxibs = Shut down only the emergency station (COX-2). Inflammation controlled; the everyday station (COX-1) still runs - stomach protected, platelets still work.

BUT - the emergency station (COX-2) also made a fire-retardant chemical (PGI2) that prevented the dry wood (platelets + blood vessels) from catching fire (clotting). Shut it down, and the wood can catch fire (thrombosis risk).

Analogy 4: The Reye's Syndrome Story (Aspirin in Children)

Imagine a child's liver is a power plant. When a virus infects the child, the power plant is already working overtime trying to fight the infection. Now you give aspirin - it's like throwing a spanner into the power plant's engine while it's already strained. The engine (mitochondria) breaks down. The power plant (liver) catches fire. The brain loses power (encephalopathy). This is Reye's syndrome.

Analogy 5: Aspirin vs Ibuprofen and Antiplatelet Protection

Imagine COX-1 in a platelet is a parking spot reserved for aspirin (aspirin's antiplatelet effect). Aspirin parks there permanently (irreversible).

Ibuprofen is a bigger car that parks in the same spot. If ibuprofen parks there first (patient takes ibuprofen before aspirin), it blocks aspirin from getting in. When ibuprofen eventually drives away (reversible), the spot is empty again - aspirin missed its chance. The platelet's COX-1 is now unmodified, and TxA2 is made freely.

This is why patients on low-dose aspirin for heart protection should NOT take ibuprofen simultaneously.

Analogy 6: The Kidney Prostaglandin Story

The kidney's blood vessels are like a garden hose with a squeeze. Normally, without NSAIDs, your body makes prostaglandins that OPEN (relax) the hose - water (blood) flows freely.

Now imagine you are dehydrated or in heart failure. Your body is already in crisis mode - squeezing all the hoses to maintain blood pressure. The prostaglandins are now working VERY HARD to keep the kidney hose open.

Give an NSAID → block prostaglandins → kidney hose suddenly gets squeezed shut → no blood to kidney → AKI.

In a healthy, well-hydrated person, the NSAID-induced loss of prostaglandins is not as dangerous. But in heart failure, dehydration, or combined with ACE inhibitors/diuretics - it is the "triple whammy" that causes catastrophic AKI.

SECTION 5: STEP-BY-STEP CLINICAL REASONING

Scenario 1: A 25-year-old woman with severe menstrual cramps

How does a doctor think?

Step 1: What is causing the pain? During menstruation, endometrial cells shed and release large amounts of prostaglandins (especially PGF2α and PGE2). These cause uterine muscle to contract strongly and also sensitize pain fibers → cramping pain.

Step 2: What drug should address the mechanism? We need to reduce prostaglandins. COX inhibitors (NSAIDs) are ideal.

Step 3: Which NSAID?

Ibuprofen: Effective, well-tolerated, available OTC - first choice
Mefenamic acid: Good choice because it both inhibits COX AND blocks prostaglandin receptors - dual mechanism
Naproxen: Longer-acting, so fewer doses needed
Avoid: Indomethacin (too toxic for this use)

Step 4: When to start? Start 1-2 days before expected onset of menses (to prevent prostaglandin surge) - not just when pain starts.

Step 5: Safety considerations?

Is she pregnant? NSAIDs can cause premature ductus closure in third trimester
Does she have asthma? AERD risk
Does she have a history of GI ulcer? Use with PPI or consider paracetamol

Scenario 2: A 65-year-old man with acute gout, knee pain

Step 1: What is going on? Uric acid crystals deposited in knee joint → phagocytes engulf crystals → release IL-1β, TNF, prostaglandins → intense inflammation, swelling, redness, excruciating pain

Step 2: What do we need? Rapid, potent anti-inflammatory action.

Step 3: NSAID choice?

Indomethacin 25-50 mg three times daily - historically preferred for acute gout (most potent, fastest onset)
Ibuprofen high dose: Also effective
Naproxen: Acceptable

Step 4: Patient factors?

Age 65 → renal function may be reduced → be cautious with NSAIDs (AKI risk)
Heart disease? → cardiovascular risk of NSAIDs
Peptic ulcer history? → add PPI or use colchicine/steroids instead
On warfarin? → avoid NSAIDs (bleeding risk)

Step 5: Alternatives if NSAIDs contraindicated?

Colchicine (blocks neutrophil migration)
Oral prednisolone
IL-1 inhibitors (anakinra, canakinumab) for refractory cases

Scenario 3: A 55-year-old with knee osteoarthritis and a history of peptic ulcer

The dilemma: Needs NSAIDs for joint pain, but has a history of peptic ulcer.

Step 1: Can we use a non-drug approach first? Weight loss, physiotherapy, topical diclofenac gel (minimal systemic absorption).

Step 2: If oral NSAID needed: Use celecoxib (COX-2 selective - spares gastric COX-1) + add omeprazole (PPI) for maximum gastric protection.

Step 3: Test and treat H. pylori if not done (H. pylori + NSAID = highest ulcer risk).

Step 4: Use lowest effective dose for shortest duration. Regular monitoring of renal function.

Scenario 4: Patient who took "many aspirin" for pain - suspected overdose

Think through:

Respiratory alkalosis first (direct stimulation of respiratory center → hyperventilation)
Then metabolic acidosis (accumulation of lactic acid, salicylic acid)
Combined = mixed respiratory alkalosis + metabolic acidosis (classic high-yield exam finding)

Management:

Urine alkalinization (IV sodium bicarbonate) → increases urinary pH → ionizes salicylate → trapped in urine → increased excretion
Activated charcoal if within 2 hours of ingestion
Dialysis for severe toxicity (salicylate level >700 mg/L, or severe metabolic acidosis, or AKI)
Do NOT acidify plasma (worsens toxicity - more drug enters brain)

SECTION 6: MEMORY TOOLS

Mnemonic 1: NSAID Adverse Effects - "GI CARB"

G - Gastric ulceration / GI bleeding I - Interstitial nephritis / increased renal toxicity C - Cardiovascular risk (MI, stroke, hypertension) A - Aspirin: Reye's syndrome in children, antiplatelet effect R - Renal effects (AKI, water retention, hyperkalemia) B - Bronchospasm (AERD - aspirin-exacerbated respiratory disease)

Mnemonic 2: Contraindications - "ARCH-3 PEEL"

A - Active peptic ulcer R - Renal failure C - Children + viral illness (aspirin → Reye's) H - Hepatic failure (severe) 3 - Third trimester of pregnancy P - Platelet disorders / anticoagulant use E - Elderly (use with caution) E - AERD / asthma L - Low GFR states (heart failure, dehydration)

Mnemonic 3: Aspirin Toxicity - "THERMAL TRIP"

Early salicylism: Tinnitus, Hyperthermia (late), Epiphorea (tears/GI irritation), Respiratory alkalosis (FIRST acid-base change), Metabolic acidosis (LATER), Agitation/confusion, Liver dysfunction (Reye's in kids)

Mnemonic 4: COX-1 Functions - "HELP"

H - Hemostasis (TxA2 in platelets) E - Epithelium protection (gastric mucosa) L - Low-flow maintenance (renal vasodilation) P - Platelet aggregation

These are what you LOSE when you block COX-1 non-selectively.

Memory Table: Drug Half-Lives (Clinically Important)

Drug	Half-life	Dosing Frequency
Aspirin	15-20 min (aspirin itself); salicylate 2-30 hrs depending on dose	Multiple times daily
Ibuprofen	~2 hours	3-4 times daily
Diclofenac	1-2 hours	2-3 times daily
Ketorolac	~5-6 hours	4-6 hourly (max 5 days)
Naproxen	~14 hours	Twice daily
Celecoxib	~11 hours	Once or twice daily
Meloxicam	~20 hours	Once daily
Piroxicam	~45-50 hours	Once daily

Visual Memory: Aspirin's Unique Irreversible Effect

Regular NSAID:
Drug molecule -----> COX enzyme (reversible block)
Remove drug ---------> COX enzyme works again
Effect lasts: as long as drug is in blood

Aspirin:
Aspirin -----> Acetylates COX enzyme (COVALENT, IRREVERSIBLE)
Remove aspirin --> COX enzyme STILL DEAD
                        |
          New COX enzyme must be synthesized
          Nucleated cells: recover in hours
          Platelets (no nucleus): NEVER recover
          Platelet effect lasts 7-10 days (platelet lifespan)

Comparison Table: Non-selective vs COX-2 Selective NSAIDs

Feature	Non-selective NSAIDs	COX-2 Selective (Coxibs)
GI ulcer risk	HIGH	Low
Platelet effect	Inhibit aggregation	Minimal/None
CV/thrombosis risk	Moderate-high (especially diclofenac, ibuprofen)	Higher (due to PGI2 loss)
Renal effects	Present	Present (COX-2 in kidney)
Can use with low-dose aspirin?	With caution (ibuprofen competes)	Yes (celecoxib spares COX-1)
Asthma/AERD risk	Yes	Yes (some risk)
Cost	Low (generic)	Higher
Examples	Ibuprofen, naproxen, indomethacin	Celecoxib, etoricoxib

SECTION 7: EXAMINER'S CORNER

Most Tested Facts

Mechanism of action: COX inhibition → reduced prostaglandin synthesis
Aspirin is the ONLY irreversible COX inhibitor (acetylation)
Aspirin is contraindicated in children with viral illness (Reye's syndrome)
Coxibs spare COX-1 → less GI toxicity but NO protection from renal toxicity or CV risk
Celecoxib has INCREASED cardiovascular thrombotic risk (PGI2 inhibition without TxA2 inhibition)
Aspirin toxicity: mixed respiratory alkalosis + metabolic acidosis
Aspirin blocks platelet TxA2 permanently for 7-10 days
Ibuprofen can antagonize aspirin's antiplatelet effect (competition for COX-1 binding)
NSAIDs contraindicated in third trimester (premature ductus closure)
AERD/Samter's Triad: Asthma + nasal polyps + aspirin sensitivity
Indomethacin is used to close patent ductus arteriosus in neonates
Ketorolac is the only NSAID available parenterally (for short-term use)
Paracetamol hepatotoxicity → NAPQI → treat with N-acetylcysteine

Most Likely Essay Questions

"Write a note on NSAIDs: mechanism of action, adverse effects, and contraindications."
"Discuss the pharmacological basis of using aspirin as an antiplatelet agent. Why is it contraindicated in children?"
"Compare and contrast non-selective NSAIDs and COX-2 selective inhibitors."
"Discuss the adverse effects of NSAIDs, explaining the underlying mechanism for each."
"Write about the management of aspirin poisoning."
"Explain the concept of aspirin-exacerbated respiratory disease (AERD)."

Most Likely Short Notes

Aspirin (mechanism + unique properties + uses + toxicity)
Celecoxib / COX-2 selective inhibitors
Indomethacin
Paracetamol / acetaminophen toxicity
Prostaglandins and their pharmacological significance
Reye's syndrome

Most Likely Viva Questions

"What is the mechanism of action of aspirin as an analgesic vs antiplatelet?"
"Why does aspirin cause Reye's syndrome in children?"
"Why do COX-2 selective inhibitors cause cardiovascular side effects?"
"What is the acid-base disturbance in aspirin poisoning?"
"Why can't aspirin's antiplatelet effect be reversed easily?"
"How does ibuprofen interact with aspirin?"
"Why are NSAIDs contraindicated in the third trimester of pregnancy?"
"What is AERD? What is the mechanism?"

Most Likely MCQs

A patient is on low-dose aspirin for MI prevention. He starts taking ibuprofen for back pain. The likely consequence is: Answer: Reduced antiplatelet effect of aspirin (ibuprofen competitively blocks COX-1, preventing aspirin's irreversible acetylation)
A child with chickenpox is given aspirin for fever. The most dangerous complication is: Answer: Reye's syndrome (encephalopathy + hepatic failure)
The mechanism of aspirin-exacerbated respiratory disease is: Answer: Shunting of arachidonic acid to the lipoxygenase pathway → increased leukotrienes → bronchoconstriction
Which NSAID is used to close patent ductus arteriosus? Answer: Indomethacin (or ibuprofen in some protocols)
Aspirin in toxic doses causes which acid-base disturbance? Answer: Mixed respiratory alkalosis + metabolic acidosis
The antidote for paracetamol toxicity is: Answer: N-acetylcysteine (NAC)
COX-2 selective inhibitors cause increased cardiovascular risk because: Answer: They inhibit PGI2 (prostacyclin) production without inhibiting platelet TxA2 → pro-thrombotic imbalance
A 70-year-old man with heart failure is given an NSAID for joint pain. What renal complication is most likely? Answer: Acute kidney injury (AKI) - prostaglandins maintaining renal blood flow are blocked

Common Traps Students Fall Into

TRAP 1: "Aspirin blocks COX-2 in inflammation - so it should be the safest NSAID." WRONG. Aspirin irreversibly blocks COX-1 (especially in platelets and stomach) and COX-2 both. Its GI and platelet effects are significant.

TRAP 2: "COX-2 inhibitors are totally safe for the GI tract." NOT TOTALLY. They reduce peptic ulcer risk significantly (clinical trials show ~50% reduction) but do not eliminate it entirely, especially with high doses. They still carry renal risks.

TRAP 3: "Paracetamol has no side effects since it doesn't inhibit COX peripherally." WRONG. Paracetamol has a narrow therapeutic index. In overdose (even relatively modest overdose in alcoholics or malnourished patients), it causes fatal hepatic necrosis.

TRAP 4: "Ibuprofen is completely safe in children." Ibuprofen IS safe (and preferred over aspirin) for fever in children, but should be used with caution in children under 6 months, and should be dose-adjusted by weight.

TRAP 5: "Aspirin toxicity = metabolic acidosis only." WRONG. The FIRST change is respiratory ALKALOSIS (direct respiratory center stimulation). Later, metabolic acidosis supervenes. The full picture = mixed disorder.

TRAP 6: "NSAIDs don't affect the kidney much." NSAIDs are a major cause of AKI, especially in at-risk populations. COX-2 selective inhibitors also cause renal effects because COX-2 is expressed in the kidney.

TRAP 7: "Celecoxib can be given freely to patients with sulfa allergy." WRONG. Celecoxib has a sulfonamide moiety. Avoid in sulfonamide allergy.

SECTION 9: HIGH-YIELD REVISION SHEET

ONE-PAGE RAPID REVIEW: NSAIDs

DEFINITION: Drugs that reduce pain, fever, and inflammation by inhibiting cyclooxygenase (COX) enzymes → reducing prostaglandin synthesis.

MECHANISM:

COX enzyme: converts arachidonic acid → PGG2 → PGH2 → prostaglandins, TxA2, PGI2
NSAIDs block COX → reduce all downstream prostanoids
COX-1 = constitutive (housekeeper: stomach protection, platelet TxA2, renal blood flow)
COX-2 = inducible (inflammation, fever, COX-2 in endothelium makes PGI2)

ASPIRIN IS UNIQUE:

Irreversible COX inhibitor (acetylation)
Antiplatelet effect: permanent for platelet lifetime (7-10 days)
Dose-dependent: low → antiplatelet; medium → analgesic/antipyretic; high → anti-inflammatory
Contraindicated in children with viral illness (Reye's syndrome)
Toxicity: mixed respiratory alkalosis + metabolic acidosis; tinnitus

COXIBS (celecoxib, etoricoxib):

Selective COX-2 inhibitors
Less GI toxicity (spare gastric COX-1)
No platelet inhibition (spare platelet COX-1)
INCREASED cardiovascular risk (block PGI2 but not TxA2)
Celecoxib: contraindicated in sulfonamide allergy
Renal effects STILL occur (COX-2 expressed in kidney)

INDOMETHACIN:

Most potent anti-inflammatory NSAID
Most GI toxic
Closes PDA in neonates
Drug of choice for: acute gout, pericarditis (with aspirin/colchicine), ankylosing spondylitis

KETOROLAC:

Only widely used parenteral NSAID
Maximum 5 days use
Potent analgesic

MEFENAMIC ACID:

Preferred for dysmenorrhea
Blocks COX AND prostaglandin receptors

PARACETAMOL:

NOT a classic NSAID (no peripheral anti-inflammatory effect)
Centrally acting antipyretic/analgesic
Toxicity: NAPQI → hepatic centrilobular necrosis
Antidote: N-acetylcysteine (NAC)

KEY ADVERSE EFFECTS:

GI: peptic ulcer, GI bleeding (COX-1 inhibition in stomach)
Cardiovascular: MI, stroke, hypertension (especially coxibs)
Renal: AKI, water/Na+ retention, hyperkalemia, interstitial nephritis
Platelet: bleeding tendency (non-selective; not coxibs)
AERD/Aspirin-sensitive asthma: leukotriene surge
Reye's syndrome (aspirin in viral illness in children)

KEY CONTRAINDICATIONS:

Active peptic ulcer, severe renal/hepatic failure
Third trimester pregnancy (premature PDA closure)
Children with viral illness (aspirin only - Reye's)
Asthma (caution - AERD)
Celecoxib: sulfonamide allergy

KEY INTERACTIONS:

Warfarin: increased bleeding
ACE inhibitors + diuretics + NSAIDs = "triple whammy" AKI
Lithium: toxicity
Methotrexate: toxicity
Ibuprofen antagonizes low-dose aspirin

PROSTAGLANDINS REVIEW:

PGE2: pain sensitization, fever, gastric protection, vasodilation
PGI2 (prostacyclin): anti-platelet, vasodilation, renal maintenance
TxA2: pro-platelet, vasoconstriction (from platelets)
PGF2α: uterine contraction (important for dysmenorrhea)

SECTION 10: SELF-ASSESSMENT

10 Short-Answer Questions with Explanations

Q1. Explain why aspirin's antiplatelet effect lasts 7-10 days but ibuprofen's antiplatelet effect only lasts a few hours.

Answer: Aspirin IRREVERSIBLY inhibits COX-1 by covalently acetylating it. Platelets are anucleate (no nucleus), so they cannot synthesize new COX-1 protein. The COX-1 remains permanently inactivated for the entire lifespan of the platelet (7-10 days).

Ibuprofen reversibly inhibits COX-1 (competitive block). Once ibuprofen is metabolized and cleared from the platelet (a few hours), COX-1 resumes function. The antiplatelet effect therefore mirrors the drug's plasma half-life (~2 hours).

Q2. A 45-year-old asthmatic patient is given aspirin for a headache and develops acute severe bronchospasm. What is the mechanism?

Answer: This is Aspirin-Exacerbated Respiratory Disease (AERD). Aspirin blocks COX enzymes, preventing arachidonic acid from entering the prostaglandin pathway. Arachidonic acid is then redirected ("shunted") into the lipoxygenase pathway, producing large amounts of cysteinyl leukotrienes (LTC4, LTD4, LTE4). Leukotrienes are powerful bronchoconstrictors and cause the acute asthma attack. Patients with asthma AND nasal polyps are particularly at risk. All non-selective NSAIDs can trigger this, as can coxibs to a lesser extent.

Q3. Why is aspirin contraindicated in children with chickenpox or influenza?

Answer: Giving aspirin to children under 12 years with viral infections (especially chickenpox/influenza) can cause Reye's syndrome - a rare but potentially fatal illness characterized by acute non-inflammatory encephalopathy and fatty liver degeneration. The exact mechanism is not fully defined, but aspirin appears to impair mitochondrial function in hepatocytes already stressed by viral infection, leading to hepatic failure and secondary brain involvement. Paracetamol or ibuprofen should be used instead for fever in children.

Q4. Explain the acid-base disturbance seen in aspirin toxicity.

Answer: There are two sequential phases:

Early/Mild toxicity: Aspirin directly stimulates the medullary respiratory center → hyperventilation → increased CO2 elimination → respiratory alkalosis (low pCO2, high pH). This is the FIRST acid-base disturbance.
Late/Severe toxicity: Aspirin uncouples oxidative phosphorylation in mitochondria → cellular metabolism shifts to anaerobic → lactic acid accumulates. Additionally, salicylic acid itself is an organic acid. These together produce metabolic acidosis (low pH, low bicarbonate, increased anion gap).

The final picture in severe poisoning is: mixed respiratory alkalosis + metabolic acidosis = classic exam finding.

Q5. Why do COX-2 selective inhibitors (coxibs) increase the risk of myocardial infarction?

Answer: In normal vasculature, there is a balance between:

TxA2 (made by platelets via COX-1): promotes platelet aggregation and vasoconstriction
PGI2/Prostacyclin (made by vascular endothelium via COX-2): inhibits platelet aggregation and causes vasodilation

COX-2 selective inhibitors (like celecoxib) block endothelial COX-2 → reduce PGI2 production. However, they do NOT block platelet COX-1, so TxA2 production continues unchecked. The balance tips toward TxA2 dominance → a pro-thrombotic, vasoconstrictive state → increased risk of coronary thrombosis → myocardial infarction. This is why rofecoxib was withdrawn from the market after the VIGOR trial showed doubling of MI risk.

Q6. How does indomethacin close patent ductus arteriosus in premature neonates?

Answer: The ductus arteriosus is a fetal blood vessel that bypasses the lungs (connecting pulmonary artery to aorta). It normally closes after birth. In premature neonates, it may remain open (patent). Prostaglandin E2 (PGE2) actively keeps the ductus arteriosus open (vasodilatory effect on ductal smooth muscle). By inhibiting COX → reducing PGE2 → ductal smooth muscle constricts and the ductus closes. Indomethacin is the traditional drug; ibuprofen IV is now also used. This is one of the most clinically important uses of NSAIDs in neonatology.

Q7. A patient on low-dose aspirin for heart protection also takes ibuprofen for arthritis. Why is this a problem?

Answer: Both aspirin and ibuprofen compete for the same binding site on COX-1 (the hydrophobic substrate-binding channel). If the patient takes ibuprofen first, ibuprofen molecules occupy and reversibly block the COX-1 active site. Aspirin, which needs to physically access and acetylate the active site to achieve its irreversible antiplatelet effect, cannot gain access while ibuprofen is bound. When ibuprofen is eventually cleared, COX-1 is unmodified (ibuprofen's block was reversible), and TxA2 production resumes. Aspirin's irreversible antiplatelet protection is therefore never achieved. The solution: take aspirin at least 30-60 minutes BEFORE ibuprofen (to allow aspirin to acetylate first), or use a different analgesic like paracetamol or a coxib that does not compete with COX-1.

Q8. Why are NSAIDs contraindicated in the third trimester of pregnancy?

Answer: Three main reasons:

Premature closure of the ductus arteriosus: In the fetus, PGE2 keeps the ductus arteriosus open (needed for fetal circulation to bypass lungs, which are not yet used). NSAID inhibition of prostaglandins can cause premature ductal closure → fetal cardiac failure and pulmonary hypertension.
Oligohydramnios: NSAIDs reduce fetal urine production (prostaglandins maintain renal blood flow in the fetus) → reduced amniotic fluid → fetal complications.
Delayed/prolonged labor: Prostaglandins (especially PGF2α) are essential for initiating and maintaining uterine contractions during labor. NSAIDs reduce them → tocolytic effect → prolonged labor.

Q9. What is the mechanism of paracetamol hepatotoxicity, and how does N-acetylcysteine (NAC) treat it?

Answer: Normal metabolism: Paracetamol is metabolized in the liver mostly by conjugation with glucuronide and sulfate (safe pathways), and a small amount by CYP2E1 to a toxic intermediate, NAPQI (N-acetyl-p-benzoquinoneimine). NAPQI is rapidly detoxified by conjugation with glutathione.

In overdose: Glucuronide/sulfate pathways are saturated. More paracetamol is forced through CYP2E1. NAPQI production overwhelms glutathione stores. Free NAPQI covalently binds to liver cell proteins → causes oxidative damage and cell death → centrilobular hepatic necrosis (zone 3, where CYP2E1 is concentrated).

NAC mechanism: NAC replenishes hepatic glutathione (it is a glutathione precursor - provides cysteine for glutathione synthesis) AND can directly react with NAPQI. This restores the capacity to detoxify NAPQI. NAC is most effective when given within 8-10 hours of ingestion, but can still benefit up to 24-36 hours later.

Q10. A 70-year-old man with chronic heart failure and osteoarthritis is prescribed an NSAID. List all the reasons why this combination is dangerous.

Answer: Multiple simultaneous risks:

AKI: Heart failure → reduced cardiac output → kidneys rely heavily on prostaglandins (PGE2, PGI2) to maintain renal blood flow by dilating afferent arterioles. NSAIDs block these prostaglandins → afferent arteriole constriction → GFR falls → acute kidney injury.
Worsening heart failure: NSAIDs cause sodium and water retention (prostaglandins normally help the kidney excrete Na+). NSAID use → Na+ and water retention → increased plasma volume → increased preload and afterload → worsening heart failure.
Hypertension: Same Na+/water retention mechanism can elevate blood pressure, further straining the failing heart.
Interaction with heart failure medications: Most CHF patients are on ACE inhibitors/ARBs (which reduce angiotensin II, itself a compensatory vasoconstrictor). ACE inhibitors + NSAIDs = "double blockade" of renal autoregulation → AKI. If also on diuretics: NSAIDs reduce the effect of diuretics AND add to renal toxicity = "triple whammy" AKI.
Cardiovascular thrombotic risk: NSAIDs (especially coxibs and diclofenac) increase MI and stroke risk - dangerous in a compromised heart.

Alternative approach: Use paracetamol for pain (does not affect prostaglandins peripherally, no CV or renal risks at therapeutic doses). Consider topical NSAIDs for local joint pain. If oral NSAIDs absolutely necessary: lowest dose, shortest duration, monitor renal function and electrolytes closely.

This complete learning note has been compiled from authoritative sources including Goodman & Gilman's The Pharmacological Basis of Therapeutics, Katzung's Basic and Clinical Pharmacology (16th Edition), Lippincott Illustrated Reviews: Pharmacology, Robbins and Cotran Pathologic Basis of Disease, Brenner and Rector's The Kidney, and Miller's Anesthesia.

End of NSAIDs Complete Learning Note

This is a shared conversation. Sign in to Orris to start your own chat.